Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYP3A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 219 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Anzenbacher, P; Anzenbacherova, E
      Cytochromes P450 and metabolism of xenobiotics

      CELLULAR AND MOLECULAR LIFE SCIENCES
    2. Whalley, PM; Bakes, D; Grime, K; Weaver, RJ
      Rapid high-performance liquid chromatographic method for the separation ofhydroxylated testosterone metabolites

      JOURNAL OF CHROMATOGRAPHY B
    3. Kullman, SW; Hinton, DE
      Identification, characterization, and ontogeny of a second cytochrome P4503A gene from the fresh water teleost medaka (Oryzias latipes)

      MOLECULAR REPRODUCTION AND DEVELOPMENT
    4. Eiselt, R; Domanski, TL; Zibat, A; Mueller, R; Presecan-Siedel, E; Hustert, E; Zanger, UM; Brockmoller, J; Klenk, HP; Meyer, UA; Khan, KK; He, YA; Halpert, JR; Wojnowski, L
      Identification and functional characterization of eight CYP3A4 protein variants

      PHARMACOGENETICS
    5. Streetman, DS; Kashuba, ADM; Bertino, JS; Kulawy, R; Rocci, ML; Nafziger, AN
      Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping

      PHARMACOGENETICS
    6. Gellner, K; Eiselt, R; Hustert, E; Arnold, H; Koch, I; Haberl, M; Deglmann, CJ; Burk, O; Buntefuss, D; Escher, S; Bishop, C; Koebe, HG; Brinkmann, U; Klenk, HP; Kleine, K; Meyer, UA; Wojnowski, L
      Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene

      PHARMACOGENETICS
    7. Eeckhoudt, SL; Desager, JP; Robert, AR; Leclercq, I; Verbeeck, RK; Horsman, Y
      Midazolam and cortisol metabolism before and after CYP3A induction in humans

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    8. Galant, C; Gala, JL; Van den Berge, V; Berliere, M; Haumont, E; Horsmans, Y
      Immunolocalisation of cytochrome P-450 3A enzymes in human breast carcinoma: Relationship with tumour differentiation and steroid receptors

      PHARMACOLOGY & TOXICOLOGY
    9. Micuda, S; Hodac, M; Sispera, L; Parizek, P; Pleskot, M; Zimova, G; Cerman, J; Martinkova, J; Pidrman, V
      Influence of amiodarone on urinary excretion of 6 beta-hydroxycortisol in humans

      PHYSIOLOGICAL RESEARCH
    10. Mihara, K; Matsumura, M; Yoshioka, E; Hanada, K; Nakasa, H; Ohmori, S; Kitada, M; Ogata, H
      Intestinal first-pass metabolism of eperisone in the rat

      PHARMACEUTICAL RESEARCH
    11. Piver, B; Berthou, F; Dreano, Y; Lucas, D
      Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components

      TOXICOLOGY LETTERS
    12. Nallani, SC; Genter, MB; Desai, PB
      Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    13. Rivory, LP; Slaviero, KA; Hoskins, JM; Clarke, SJ
      The erythromycin breath test for the prediction of drug clearance

      CLINICAL PHARMACOKINETICS
    14. Palmer, JL; Scott, RJ; Gibson, A; Dickins, M; Pleasance, S
      An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    15. Yeo, KR; Yeo, WW
      Inhibitory effects of verapamil and diltiazem on simvastatin metabolism inhuman liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    16. Boulton, DW; Arnaud, P; DeVane, CL
      A single dose of methadone inhibits cytochrome P-4503A activity in healthyvolunteers as assessed by the urinary cortisol ratio

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    17. Stupans, I; Murray, M; Kirlich, A; Tuck, KL; Hayball, PJ
      Inactivation of cytochrome P450 by the food-derived complex phenol oleuropein

      FOOD AND CHEMICAL TOXICOLOGY
    18. Chalasani, N; Gorski, JC; Patel, NH; Hall, SD; Galinsky, RE
      Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts

      HEPATOLOGY
    19. Stormer, E; van Moltke, LL; Perloff, MD; Greenblatt, DJ
      P-glycoprotein interactions of nefazodone and trazodone in cell culture

      JOURNAL OF CLINICAL PHARMACOLOGY
    20. McCune, JS; Lindley, C; Decker, JL; Williamson, KM; Meadowcroft, AM; Graff, D; Sawyer, WT; Blough, DK; Pieper, JA
      Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan

      JOURNAL OF CLINICAL PHARMACOLOGY
    21. Schwartz, JB
      Race but not age affects erythromycin breath test results in older hypertensive men

      JOURNAL OF CLINICAL PHARMACOLOGY
    22. Turan, VK; Mishin, VM; Thomas, PE
      Clotrimazole is a selective and potent inhibitor of rat cytochrome P450 3Asubfamily-related testosterone metabolism

      DRUG METABOLISM AND DISPOSITION
    23. Obach, RS; Zhang, QY; Dunbar, D; Kaminsky, LS
      Metabolic characterization of the major human small intestinal cytochrome P450S

      DRUG METABOLISM AND DISPOSITION
    24. Yu, AM; Dong, HJ; Lang, D; Haining, RL
      Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6

      DRUG METABOLISM AND DISPOSITION
    25. Yu, AM; Haining, RL
      Comparative contribution to dextromethorphan metabolism by cytochrome P450isoforms in vitro: Can dextromethorphan be used as a dual probe for both CYP2D6 and CYP3A activities?

      DRUG METABOLISM AND DISPOSITION
    26. Christ, B; Brockmeier, D; Hauck, EW; Friemann, S
      Interactions of sildenafil and tacrolimus in men with erectile dysfunctionafter kidney transplantation

      UROLOGY
    27. Emoto, C; Yamazaki, H; Iketaki, H; Yamasaki, S; Satoh, T; Shimizu, R; Suzuki, S; Shimada, N; Nakajima, M; Yokoi, T
      Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drugoxidation activities in hepatic and intestinal microsomes from mouse and human

      XENOBIOTICA
    28. Bray, BJ; Rosengren, RJ
      Retinol potentiates acetaminophen-induced hepatotoxicity in the mouse: Mechanistic studies

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    29. Backes, WL; Serron, SC
      Re: Ethylbenzene induces microsomal oxygen free radical generation: Antibody-directed characterization of the responsible cytochrome P450 enzymes (Toxicol. Appl. Pharmacol. 164, 305-311, 2000) - Reply

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    30. Yasui-Furukori, N; Kondo, T; Kubota, T; Otake, H; Ohkubo, T; Nagasaki, T; Sugawara, K; Chiba, K; Otani, K; Kaneko, S
      No correlations between the urinary ratio of 6 beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    31. Ring, BJ; Eckstein, JA; Gillespie, JS; Binkley, SN; Vandenbranden, M; Wrighton, SA
      Identification of the human cytochromes P450 responsible for in vitro formation of R- and S-norfluoxetine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    32. Engman, HA; Lennernas, H; Taipalensuu, J; Otter, C; Leidvik, B; Artursson, P
      CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies

      JOURNAL OF PHARMACEUTICAL SCIENCES
    33. Baron, JM; Holler, D; Schiffer, R; Frankenberg, S; Neis, M; Merk, HF; Jugert, FK
      Expression of multiple cytochrome P450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    34. Schmidt, LE; Olsen, AK; Stentoft, K; Rasmussen, A; Kirkegaard, P; Dalhoff, K
      Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    35. Zhu, B; Ou-Yang, DS; Chen, XP; Huang, SL; Tan, ZR; He, N; Zhou, HH
      Assessment of cytochrome P450 activity by a five-drug cocktail approach

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    36. Chiou, WL; Jeong, HY; Wu, TC; Ma, C
      Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    37. Wang, ZQ; Gorski, C; Hamman, MA; Huang, SM; Lesko, LJ; Hall, SD
      The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    38. Yu, KS; Cho, JY; Shon, JH; Bae, KS; Yi, SY; Lim, HS; Jang, IJ; Shin, SG
      Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    39. Niemi, M; Neuvonen, PJ; Kivisto, KT
      The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    40. Zimova, G; Chladek, J; Martinkova, J; Beranek, M
      HPLC determination of dextromethorphan and its metabolites in plasma

      CHEMICKE LISTY
    41. Nakayama, K; Sudo, Y; Sasaki, Y; Iwata, H; Takahashi, M; Kamataki, T
      Studies on transcriptional regulation of Cyp3a16 gene in mouse livers by application of direct DNA injection method

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    42. He, YQ; Roussel, F; Halpert, JR
      Importance of amino acid residue 474 for substrate specificity of canine and human cytochrome p450 3A enzymes

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    43. Celander, MC; Moore, MJ; Stegeman, JJ
      Cellular localization of CYP3A proteins in various tissues from pilot whale (Globicephala melas)

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    44. Overton, PG; Marrow, LP; Brain, PF; Clark, D
      Certain clinically-utilized antibiotics enhance the behavioural effects ofcocaine

      ADDICTION BIOLOGY
    45. Rivory, LP; Slaviero, K; Seale, JP; Hoskins, JM; Boyer, M; Beale, PJ; Millward, MJ; Bishop, JF; Clarke, SJ
      Optimizing the erythromycin breath test for use in cancer patients

      CLINICAL CANCER RESEARCH
    46. Cotreau, MM; von Moltke, LL; Beinfeld, MC; Greenblatt, DJ
      Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    47. Lewis, DFV; Ioannides, C; Parke, DV; Schulte-Hermann, R
      Quantitative structure-activity relationships in a series of endogenous and synthetic steroids exhibiting induction of CYP3A activity and hepatomegaly associated with increased DNA synthesis

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    48. Zaigler, M; Tantcheva-Poor, I; Fuhr, U
      Problems and perspectives of phenotyping for drug-metabolizing enzymes in man

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    49. Paine, MF; Davis, CL; Shen, DD; Marsh, CL; Raisys, VA; Thummel, KE
      Can oral midazolam predict oral cyclosporine disposition?

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    50. Kishimoto, W; Takano, J; Senda, C; Ishiguro, N; Sakai, K; Igarashi, T
      Quantitative prediction of in vivo drug interactions between nevirapine and antifungal agents from in vitro data in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    51. Matsunaga, T; Shibayama, K; Higuchi, S; Tanaka, H; Watanabe, K; Yamamoto, I
      Characterization of microsomal alcohol oxygenase catalyzing the oxidation of 7-hydroxy-Delta(8)-tetrahydrocannabinol to 7-oxo-Delta(8)-tetrahydrocannabinol in rat liver

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    52. Masuyama, H; Hiramatsu, Y; Kunitomi, M; Kudo, T; MacDonald, PN
      Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription

      MOLECULAR ENDOCRINOLOGY
    53. Joannard, F; Galisteo, M; Corcos, L; Guillouzo, A; Lagadic-Gossmann, D
      Regulation of phenobarbital-induction of CYP2B and CYP3A genes in rat cultured hepatocytes: involvement of several serine/threonine protein kinases and phosphatases

      CELL BIOLOGY AND TOXICOLOGY
    54. Yamamoto, N; Tamura, T; Kamiya, Y; Sekine, I; Kunitoh, H; Saijo, N
      Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol

      JOURNAL OF CLINICAL ONCOLOGY
    55. Homma, M; Beckerman, K; Hayashi, S; Jayewardene, AL; Oka, K; Gambertoglio, JG; Aweeka, FT
      Liquid chromatographic determination of urinary 6 beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    56. Martin, C; Ellouk-Achard, S; Dutertre-Catella, H; Thevenin, M; Warnet, JM; Claude, JR
      Adverse effects of dexamethasone used as CYP3A inducer in rats

      SCIENCES ET TECHNIQUES DE L ANIMAL DE LABORATOIRE
    57. Masica, AL; Azie, NE; Brater, DC; Hall, SD; Jones, DR
      Intravenous diltiazem and CYP3A-mediated metabolism

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    58. McLure, JA; Miners, JO; Birkett, DJ
      Nonspecific binding of drugs to human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    59. Moore, JT; Kliewer, SA
      Use of the nuclear receptor PXR to predict drug interactions

      TOXICOLOGY
    60. Grasela, DM; LaCreta, FP; Kollia, GD; Randall, DM; Uderman, HD
      Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers

      PHARMACOTHERAPY
    61. Bardelmeijer, HA; van Tellingen, O; Schellens, JHM; Beijnen, JH
      The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery

      INVESTIGATIONAL NEW DRUGS
    62. Hurh, E; Lee, EJ; Kim, YG; Kim, SY; Kim, SH; Kim, YC; Lee, MG
      Effects of physostigmine on the pharmacokinetics of intravenous parathion in rats

      BIOPHARMACEUTICS & DRUG DISPOSITION
    63. Krecic-Shepard, ME; Barnas, CR; Slimko, J; Jones, MP; Schwartz, JB
      Gender-specific effects on verapamil pharmacokinetics and pharmacodynamicsin humans

      JOURNAL OF CLINICAL PHARMACOLOGY
    64. Mayhew, BS; Jones, DR; Hall, SD
      An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4by metabolic intermediate complex formation

      DRUG METABOLISM AND DISPOSITION
    65. Bowen, WP; Carey, JE; Miah, A; McMurray, HF; Munday, PW; James, RS; Coleman, RA; Brown, AM
      Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction

      DRUG METABOLISM AND DISPOSITION
    66. Choo, EF; Leake, B; Wandel, C; Imamura, H; Wood, AJJ; Wilkinson, GR; Kim, RB
      Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes

      DRUG METABOLISM AND DISPOSITION
    67. Sinclair, JF; Szakacs, JG; Wood, SG; Walton, HS; Bement, JL; Gonzalez, FJ; Jeffery, EH; Wrighton, SA; Bement, WJ; Sinclair, PR
      Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    68. Wang, JS; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Effects of metronidazole on midazolam metabolism in vitro and in vivo

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    69. von Moltke, LL; Durol, ALB; Duan, SX; Greenblatt, DJ
      Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    70. Martinez, C; Gervasini, G; Agundez, JAG; Carrillo, JA; Ramos, SI; Garcia-Gamito, FJ; Gallardo, L; Benitez, J
      Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    71. Benatar, A; Feenstra, A; Decraene, T; Vandenplas, Y
      Effects of cisapride on corrected QT interval, heart rate, and rhythm in infants undergoing polysomnography

      PEDIATRICS
    72. Wulff, H; Miller, MJ; Hansel, W; Grissmer, S; Cahalan, MD; Chandy, KG
      Design of a potent and selective inhibitor of the intermediate-conductanceCa2+-activated K+ channel, IKCa1: A potential immunosuppressant

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    73. Ladona, MG; Gonzalez, ML; Rane, A; Peter, RM; de la Torre, R
      Cocaine metabolism in human fetal and adult liver microsomes is related tocytochrome P450 3A expression

      LIFE SCIENCES
    74. Tateishi, T; Watanabe, M; Kumai, T; Tanaka, M; Moriya, H; Yamaguchi, S; Satoh, T; Kobayashi, S
      CYP3A is responsible for N-dealkylation of haloperidol and bromperidol andoxidation of their reduced forms by human liver microsomes

      LIFE SCIENCES
    75. Fontaine, F; de Sousa, G; Burcham, PC; Duchene, P; Rahmani, R
      Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes

      LIFE SCIENCES
    76. Ibrahim, RB; Wilson, JG; Thorsby, ME; Edwards, DJ
      Effect of buprenorphine on CYP3A activity in rat and human liver microsomes

      LIFE SCIENCES
    77. Takanaga, H; Ohnishi, A; Yamada, S; Matsuo, H; Morimoto, S; Shoyama, Y; Ohtani, H; Sawada, Y
      Polymethoxylated flavones in orange juice are inhibitors of P-glycoproteinbut not cytochrome P450 3A4

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    78. Stupans, I; Stretch, G; Hayball, P
      Olive oil phenols inhibit human hepatic microsomal activity

      JOURNAL OF NUTRITION
    79. Xiang, H; Tschirret-Guth, RA; de Montellano, PRO
      An A245T mutation conveys on cytochrome P450(eryF) the ability to oxidize alternative substrates

      JOURNAL OF BIOLOGICAL CHEMISTRY
    80. Sadeque, AJM; Wandel, C; He, HB; Shah, S; Wood, AJJ
      Increased drug delivery to the brain by P-glycoprotein inhibition

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    81. Krecic-Shepard, ME; Barnas, CR; Slimko, J; Schwartz, JB
      Faster clearance of sustained release verapamil in men versus women: Continuing observations on sex-specific differences after oral administration ofverapamil

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    82. Seidegard, J
      Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    83. Backman, JT; Maenpaa, J; Belle, DJ; Wrighton, SA; Kivisto, KT; Neuvonen, PJ
      Lack of correlation between in vitro and in vivo studies on the effects oftangeretin and tangerine juice on midazolam hydroxylation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    84. Gorski, JC; Hall, SD; Becker, P; Affrime, MB; Cutler, DL; Haehner-Daniels, B
      In vivo effects of interleukin-10 on human cytochrome P450 activity

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    85. Hosagrahara, VP; Hansen, LK; Beilman, GJ; Remmel, RP
      Evaluation of the effect of culture matrices on induction of CYP3A isoforms in cultured porcine hepatocytes

      CHEMICO-BIOLOGICAL INTERACTIONS
    86. Quintieri, L; Rosato, A; Napoli, E; Sola, F; Geroni, C; Floreani, M; Zanovello, P
      In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: Role of cytochrome P450 3A

      CANCER RESEARCH
    87. Zalma, A; von Moltke, LL; Granda, BW; Harmatz, JS; Shader, RI; Greenblatt, DJ
      In vitro metabolism of trazodone by CYP3A: Inhibition by ketoconazole and human immunodeficiency viral protease inhibitors

      BIOLOGICAL PSYCHIATRY
    88. Franklin, MR; Phillips, JD; Kushner, JP
      CYP3A-inducing agents and the attenuation of uroporphyrin accumulation andexcretion in a rat model of porphyria cutanea tarda

      BIOCHEMICAL PHARMACOLOGY
    89. Johnson, TN; Tanner, MS; Tucker, GT
      A comparison of the ontogeny of enterocytic and hepatic cytochromes P450 3A in the rat

      BIOCHEMICAL PHARMACOLOGY
    90. Sinclair, JF; Szakacs, JG; Wood, SG; Kostrubsky, VE; Jeffery, EH; Wrighton, SA; Bement, WJ; Wright, D; Sinclair, PR
      Acetaminophen hepatotoxicity precipitated by short-term treatment of rats with ethanol and isopentanol - Protection by triacetyloleandomycin

      BIOCHEMICAL PHARMACOLOGY
    91. Moubarak, AS; Rosenkrans, CF
      Hepatic metabolism of ergot alkaloids in beef cattle by cytochrome P450

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    92. Kullman, SW; Hamm, JT; Hinton, DE
      Identification and characterization of a cDNA encoding cytochrome P450 3A from the fresh water teleost medaka (Oryzias latipes)

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    93. Tassaneeyakul, W; Guo, LQ; Fukuda, K; Ohta, T; Yamazoe, Y
      Inhibition selectivity of grapefruit juice components on human cytochromesP450

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    94. Czekaj, P
      Phenobarbital-induced expression of cytochrome P450 genes

      ACTA BIOCHIMICA POLONICA
    95. Wanwimolruk, S; Zhang, H; Coville, PF; Saville, DJ; Davis, LS
      In vitro hepatic metabolism of a CYP3A-mediated drug, quinine, in Adelie penguins

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    96. Reilly, PEB; Mason, SR; Read, MA
      Human, rat and crocodile liver microsomal monooxygenase activities measured using diazepam and nifedipine: effects of CYP3A inhibitors and relationship to immunochemically detected CYP3A apoprotein

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    97. Kashuba, ADM; Nafziger, AN; Kearns, GL; Leeder, JS; Gotschall, R; Gaedigk, A; Bertino, JS
      Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity

      PHARMACOGENETICS
    98. Samojlik, I; Raskovic, A; Dakovic-Svajcer, K; Mikov, M; Jakovljevic, V
      The effect of paracetamol on peritoneal reflex after single and multiple grapefruit ingestion

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    99. Sumida, A; Yamamoto, I; Zhou, Q; Morisaki, T; Azuma, J
      Evaluation of induction of CYP3A mRNA using the HepG2 cell line and reverse transcription PCR

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    100. Chladek, J; Zimova, G; Martinkova, J; Tuma, I
      Intra-individual variability and influence of urine collection period on dextromethorphan metabolic ratios in healthy subjects

      FUNDAMENTAL & CLINICAL PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/01/21 alle ore 23:15:05